PET/CT Assessment of Tumor Perfusion in Patients With Renal Cell Carcinoma
Status:
Terminated
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
Given the growing importance of anti-angiogenic therapies in the treatment of metastatic
renal carcinoma, it is expected that this trial will establish the preliminary data needed to
apply for funding of a larger clinical investigation of the potential role of PET perfusion
imaging in management of renal carcinoma, and potentially other cancers.